RGLS / Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug

Long-established in the Biotechnology industry, Regulus Therapeutics Inc ( RGLS , Financial) has enjoyed a stellar reputation. It has recently witness more_horizontal

Regulus (RGLS) surges as it completes enrollment in the first cohort to evaluate RGLS8429 for kidney disease. more_horizontal

Regulus Therapeutics, Inc. (NASDAQ:RGLS ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Company Participants Crispina Calsada - CFO Ja more_horizontal

SAN DIEGO , Sept. 2, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and developme more_horizontal

Are these penny stocks on your watchlist right now? The post Check These 3 Penny Stocks Out For Your Watchlist  appeared first on Penny Stocks to Buy more_horizontal

These penny stocks all have 10x potential or greater during the remainder of 2022. They are risky but relatively straightforward. more_horizontal

Here are three tips for trading penny stocks during a bear market The post How to Trade Penny Stocks When the Stock Market Crashes appeared first on P more_horizontal

Regulus Therapeutics, Inc. (NASDAQ:RGLS ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Crispina Calsada - CFO Joseph more_horizontal